Keryx Biopharmaceuticals (KERX)

3.20 -0.10  -3.03%  Feb 10, 11:00PM Go Pro
Watch
View Full Chart KERX Price Chart

Key Stats

Market Cap 223.04M
Revenue Growth
Profit Margin
Earnings Yield -11.88%
Dividend Yield 0.00%
Earnings Per Share TTM -0.38
PE Ratio
Price / Sales Ratio
52 Week High 5.55
52 Week Low 2.27
Beta 3.23
View Pro Ratings Details

YCharts Pro Ratings

Go Pro.
Learn More
  • Pro Value Score Go Pro
  • Pro Fundamental Score Go Pro
  • Pro Valuation from Historical Multiples Go Pro

News

Feb 10 DIARY-U.S. MEETINGS/WEEK AHEAD
Feb 09 Keryx to Present at 14th Annual BIO CEO & Investor Conference; $KERX http://stks.co/2LF8 by keryxbiopharma
Feb 08 Buy, Sell, or Hold: Ariad Pharmaceuticals Fool
Feb 08 LOOK FOR $kerx TO RUN TRU .50 by Proptr4d3r
Feb 08 $KERX well bid by Proptr4d3r
Feb 08 Keryx Biopharmaceuticals to Present at 14th Annual BIO CEO and Investor Conference PR Newswire
Feb 07 $KERX sold the conplete long position, adding onto $CHTP $AMRN $PLX as they have great potential to run upto 100%, $SPY not bad today $$ by peterumble
Feb 07 keep buying the dips in $KERX... by Proptr4d3r
Feb 06 Worker Bees Today: $SODA $GMCR $GILD $ANR $GOOG $FSLR $GCI $KERX $URI $IPGP $OII $DIS $ALXN $YONG by Fibline
Feb 06 $PLX $AMRN $KERX $SPY $AAPL #BOOM BOOM $$ by peterumble
Feb 06 Stocks To Watch Week Of Feb. 6
Feb 03 3 Hot Picks On The Way Up

Profile

Exchange: NASDAQCM       Sector: Healthcare       Industry: Drug Manufacturers - Major

1 Year Total Return Performance

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Keryx Biopharmaceuticals is down N/A over the last year vs S&P 500 Total Return up N/A, AEterna Zentaris down N/A, and Astex Pharmaceuticals up N/A.

  • KERX Total Returns
  • ^SPXTR Total Returns
  • AEZS Total Returns
  • ASTX Total Returns

Fundamentals

Fundamental analysis of a business involves analyzing its financial statements and health, its management and competitive advantages. The key financial statements of a company are the income statement, balance sheet and cash flow statement.

Income Statement View Statement

Get Quote for

Pro Strategies Featuring KERX

Did Keryx Biopharmaceuticals make it into our Pro Portfolio Strategies?

Start your YCharts Pro membership now to find out.

KERX Charts

Recent Quotes

Symbol Price Chg Chg % Market Cap
KERX 3.20 -0.10 -3.03% 223.04M
SUNH 4.49 -0.20 -4.26% 112.88M
AKAM 38.43 0.37 0.97% 6.90B
HOKU 0.80 -0.06 -7.27% 44.09M
PSMT 72.03 0.83 1.17% 2.15B
LONG 16.58 -0.07 -0.43% 185.36M
FOLD 6.70 -0.08 -1.18% 231.82M
CREE 28.35 -1.47 -4.93% 3.29B
WPCS 1.65 -0.01 -0.60% 11.47M
IACI 45.05 -0.32 -0.71% 3.70B
You must be signed in to use watchlists.
Sign In or Register
Create Watchlist from Stock Quotes
Close